Intellipharmaceuticals (IPCI) Reports In-Line Q2 Loss
Tweet
Share
E-mailGet Alerts IPCI Hot Sheet
Join SI Premium – FREE
Intellipharmaceuticals International, Inc. (Nasdaq: IPCI) reported Q2 loss of ($0.12), in-line with the analyst estimate of ($0.12).
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Tvardi Therapeutics (TVRD) Tops Q2 EPS by 1c
- Algorhythm Holdings (RIME) Tops Q2 EPS by 54c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
